regulatory
confidence high
sentiment negative
materiality 0.90
CONTRAFECT Corp: Nasdaq/NYSE listing notice — ContraFect receives Nasdaq delisting notice; trading suspended Nov 9 due to equity deficiency
CONTRAFECT Corp
- Nasdaq Panel determined to delist CFRX common stock due to failure to meet $2.5M stockholders' equity requirement and no alternative compliance.
- Trading suspension effective at opening on November 9, 2023.
- Company has 15 days to request review by Listing Council; decision not yet made.
- Stock expected to be eligible for OTC trading, but no assurance of admission.
- Company previously disclosed non-compliance in August 2023; hearing did not reverse determination.